Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.590
-0.020 (-0.43%)
Apr 20, 2026, 1:37 PM EDT - Market open
Cytek Biosciences Market Cap
Cytek Biosciences has a market cap or net worth of $590.05 million as of April 20, 2026. Its market cap has increased by 15.44% in one year.
Market Cap
590.05M
Enterprise Value
354.83M
1-Year Change
15.44%
Ranking
Category
Stock Price
$4.59
Market Cap Chart
Since the IPO on July 23, 2021, Cytek Biosciences's market cap has decreased from $2.26B to $590.05M, a decrease of -73.90%. That is a compound annual growth rate of -24.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 592.62M | -8.22% |
| Dec 31, 2025 | 645.72M | -22.76% |
| Dec 31, 2024 | 835.98M | -32.38% |
| Dec 29, 2023 | 1.24B | -10.21% |
| Dec 30, 2022 | 1.38B | -36.91% |
| Dec 31, 2021 | 2.18B | -3.47% |
| Jul 23, 2021 | 2.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CeriBell | 797.62M |
| BrainsWay | 626.56M |
| SI-BONE | 622.29M |
| Tactile Systems Technology | 585.37M |
| Beta Bionics | 578.41M |
| NeuroPace | 545.07M |
| Pacific Biosciences of California | 510.38M |
| Orthofix Medical | 510.24M |